BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7370061)

  • 1. Familial chondrocalcinosis. Prevalence in Northern Spain and clinical features in five pedigrees.
    Rodriguez-Valverde V; Tinture T; Zuñiga M; Peña J; Gonzalez A
    Arthritis Rheum; 1980 Apr; 23(4):471-8. PubMed ID: 7370061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial articular chondrocalcinosis in Spain.
    Balsa A; Martín-Mola E; Gonzalez T; Cruz A; Ojeda S; Gijón-Baños J
    Ann Rheum Dis; 1990 Jul; 49(7):531-5. PubMed ID: 2383079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary articular chondrocalcinosis. Clinical and genetic features in 13 pedigrees.
    Rodriguez-Valverde V; Zuniga M; Casanueva B; Sanchez S; Merino J
    Am J Med; 1988 Jan; 84(1):101-6. PubMed ID: 3422129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families.
    Doherty M; Hamilton E; Henderson J; Misra H; Dixey J
    Br J Rheumatol; 1991 Feb; 30(1):10-5. PubMed ID: 1846765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
    Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
    Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial chondrocalcinosis in the Spanish population.
    Fernandez Dapica MP; Gómez-Reino JJ
    J Rheumatol; 1986 Jun; 13(3):631-3. PubMed ID: 3735284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium pyrophosphatase dihydrate (CPPD) crystal deposition disease in a teaching hospital in Kuwait.
    Malaviya AN; Al-Shari IM; Al-Shayeb AR; Shehab D; Hussain MA; Al-Mutairy M; Roberts OM; Al-Ghuriear S
    Ann Rheum Dis; 2001 Apr; 60(4):416-9. PubMed ID: 11247877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of sternoclavicular joint calcium pyrophosphate dihydrate crystal deposition on computed tomography.
    Shirazian H; Chang EY; Wolfson T; Gamst AC; Chung CB; Resnick DL
    Clin Imaging; 2014; 38(4):380-383. PubMed ID: 24642252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium pyrophosphate deposition disease: a review of epidemiologic findings.
    Abhishek A
    Curr Opin Rheumatol; 2016 Mar; 28(2):133-9. PubMed ID: 26626724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chondrocalcinosis or calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. Report of a familial case].
    Fantechi V; Lazzeri S; Baldoni D; Maranghi P
    Radiol Med; 1993 Jun; 85(6):850-3. PubMed ID: 8337446
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hereditary articular chondrocalcinosis in the Osona region (Barcelona): presentation of 3 families].
    Sanmartí R; Pañella D; Brancós MA; Anglada A
    Med Clin (Barc); 1989 May; 92(20):780-3. PubMed ID: 2796417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium pyrophosphate dihydrate crystal deposition disease.
    Bencardino JT; Hassankhani A
    Semin Musculoskelet Radiol; 2003 Sep; 7(3):175-85. PubMed ID: 14593559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial articular chondrocalcinosis: study of an Alsatian family].
    Netter P; Loeuille D; Jouzeau JY; Gillet P; Peterschmitt J; Pourel J; Gaucher A
    Bull Acad Natl Med; 2001; 185(2):417-24; discussion 424-6. PubMed ID: 11474594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.
    Andrew LJ; Brancolini V; de la Pena LS; Devoto M; Caeiro F; Marchegiani R; Reginato A; Gaucher A; Netter P; Gillet P; Loeuille D; Prockop DJ; Carr A; Wordsworth BF; Lathrop M; Butcher S; Considine E; Everts K; Nicod A; Walsh S; Williams CJ
    Am J Hum Genet; 1999 Jan; 64(1):136-45. PubMed ID: 9915952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
    Williams CJ; Zhang Y; Timms A; Bonavita G; Caeiro F; Broxholme J; Cuthbertson J; Jones Y; Marchegiani R; Reginato A; Russell RG; Wordsworth BP; Carr AJ; Brown MA
    Am J Hum Genet; 2002 Oct; 71(4):985-91. PubMed ID: 12297989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary chondrocalcinosis in a Tunisian family.
    Hamza M; Meddeb N; Bardin T
    Clin Exp Rheumatol; 1992; 10(1):43-9. PubMed ID: 1551278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary chondrocalcinosis in a Mexican-American family.
    Richardson BC; Chafetz NI; Ferrell LD; Zulman JI; Genant HK
    Arthritis Rheum; 1983 Nov; 26(11):1387-96. PubMed ID: 6639697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of primary articular chondrocalcinosis.
    Zitnan D; Sitaj S
    Czech Med; 1979; 2(3):89-103. PubMed ID: 535502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease.
    Netter P; Bardin T; Bianchi A; Richette P; Loeuille D
    Joint Bone Spine; 2004 Sep; 71(5):365-8. PubMed ID: 15474385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bartter's syndrome and chondrocalcinosis: a possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals.
    Salvarani C; Rossi F; Macchioni PL; Baricchi R; Capozzoli N; Castellani S; Ghirelli L; Veneziani M; Scarti L; Portioli I
    Clin Exp Rheumatol; 1989; 7(4):415-20. PubMed ID: 2686877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.